A Phase 4 Observational, Real-World Study of 20-valent Pneumococcal Conjugate Vaccine Effectiveness Against Vaccine-Type Invasive Pneumococcal Disease in Adults Aged 65 years and above

ENCePP Code of conduct

Yes

Data sources

• Data source(s), other:
  Data sources per IPD patient, including serotyping, patient-level information and exposure ascertainment will differ across study sites and may include national/regional IPD surveillance system, patient medical records, and vaccination registries. Study sites will submit a de-identified dataset to the study sponsor.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No